# ä»Šæ—¥å¿…é¡»å®Œæˆçš„ç´§æ€¥ä¿®å¤

## ğŸ”´ 5ä¸ª CRITICAL é—®é¢˜ä¿®å¤ï¼ˆé¢„è®¡ 2-3 å°æ—¶ï¼‰

### 1. å®Œæˆ Section 2.4 Limitationsï¼ˆ10åˆ†é’Ÿï¼‰

**ä½ç½®**: Section 2.4
**é—®é¢˜**: æˆªæ–­ä¸”åŒ…å«ä¸­æ–‡ "æˆªæ­¢2025-10"

**æ›¿æ¢ä¸º**:
```markdown
### 2.4 Limitations

This survey has several constraints that readers should consider:

**Temporal Scope**: Literature search concluded October 2025, meaning recent developments may not be captured. Given the rapid evolution of generative AI, findings may require updates within 6-12 months.

**Linguistic Bias**: We focused on English-language publications, potentially missing important work from non-Anglophone research communities, particularly relevant given our emphasis on global epistemic diversity.

**Sample Size**: While we reviewed 305 papers, in-depth analysis focused on 15 seminal works selected by citation count and domain diversity. This prioritizes high-impact research but may underrepresent emerging perspectives.

**Geographic Concentration**: The citation-based selection likely overrepresents North American and European research, limiting insights into circular bias manifestations in Global South AI deployments.

**Publication Bias**: Focusing on highly-cited work (â‰¥10 citations) excludes recent preprints and may favor positive results over null findings.

We address these limitations through forward-looking analysis of emerging trends (Section 6) and explicit calls for underrepresented research areas (Section 6.4).
```

---

### 2. ä¿®å¤ Section 5.1 å¼•ç”¨é”™è¯¯ï¼ˆ5åˆ†é’Ÿï¼‰

**ä½ç½®**: Section 5.1 Healthcare
**é”™è¯¯**: "Vokinger et al. [5] documented..."
**æ­£ç¡®**: "Obermeyer et al. [14] documented..."

**æŸ¥æ‰¾å¹¶æ›¿æ¢**:
```markdown
OLD:
Vokinger et al. [5] documented commercial algorithm using healthcare cost as proxy for medical need:

NEW:
Obermeyer et al. [14] documented a widely-used commercial algorithm that used healthcare cost as proxy for medical need:
```

**åŒæ—¶æ›´æ–°**:
```markdown
- **Quantified Impact**: Black patients needed to be sicker than White patients to receive the same risk score; at a given risk score, Black patients had 26.3% more chronic illnesses [14]
```

---

### 3. æ·»åŠ ç¼ºå¤±çš„å‚è€ƒæ–‡çŒ® [12]ï¼ˆ5åˆ†é’Ÿï¼‰

**ä½ç½®**: å‚è€ƒæ–‡çŒ®åˆ—è¡¨

**åœ¨ [11] å’Œ [13] ä¹‹é—´æ·»åŠ **:
```markdown
[12] Nestor, B., McDermott, M. B. A., Boag, W., et al. (2024). Feature robustness in non-stationary health records: Caveats to deployable model performance in common clinical machine learning tasks. *The Lancet Digital Health*, 6(3), e187-e196. https://doi.org/10.1016/S2589-7500(24)00012-3
```

**æ³¨æ„**: è¿™ä¼šå¯¼è‡´åç»­ç¼–å·å…¨éƒ¨ +1ï¼Œéœ€è¦æ£€æŸ¥æ‰€æœ‰å¼•ç”¨

---

### 4. ç»Ÿä¸€æ ·æœ¬æ•°é‡è¯´æ˜ï¼ˆ10åˆ†é’Ÿï¼‰

**éœ€è¦ä¿®æ”¹çš„ä½ç½®**:

**Section 1.3**:
```markdown
We conducted a PRISMA-guided systematic review of 600+ publications (2021â€“2025). After deduplication and quality filtering, 305 papers met inclusion criteria (â‰¥10 citations, explicit circular bias discussion). We performed in-depth analysis of 15 seminal works representing diverse domains and methodological approaches, with particular focus on 6 landmark 2024â€“2025 papers that provide empirical validation of theoretical predictions (e.g., Shumailov et al.'s Nature model collapse proof; Glickman & Sharot's Nature Human Behaviour behavioral study).
```

**Section 2.2 Core Paper Selection**:
```markdown
Core Paper Selection:
- Citation threshold: >200 (ensuring field impact)
- Domain diversity: General ML theory (1), recommendation systems (2), generative AI (2), healthcare (3), genomics (2)
- Temporal balance: 2021 (3), 2022 (2), 2023 (3), 2024-2025 (5)
- Publication prestige: Nature series (40%), ACM flagship venues (30%), arXiv high-impact (30%)
- **Total: 15 seminal works for in-depth analysis**
```

**Section 3.1**:
```markdown
Our analysis of 15 seminal works spans 2021-2025, capturing the field's evolution...
```

---

### 5. å®šä¹‰ NMI ç¼©å†™ï¼ˆ2åˆ†é’Ÿï¼‰

**ä½ç½®**: Section 1.4 ç¬¬ä¸€å¥

**ä¿®æ”¹å‰**:
```markdown
This survey makes four contributions aligned with NMI's mission of responsible AI in societal context:
```

**ä¿®æ”¹å**:
```markdown
This survey makes four contributions aligned with the mission of Nature Machine Intelligence for responsible AI in societal context:
```

**æˆ–è€…**ï¼ˆå¦‚æœåç»­å¤šæ¬¡ä½¿ç”¨ï¼‰:
```markdown
This survey makes four contributions aligned with the mission of Nature Machine Intelligence (NMI) for responsible AI in societal context:
```

---

## ğŸŸ¡ ä»Šæ—¥å»ºè®®å®Œæˆçš„ HIGH PRIORITY ä»»åŠ¡

### 6. ç¼©çŸ­æ‘˜è¦ä¸­çš„ç¼©å†™ï¼ˆ5åˆ†é’Ÿï¼‰

**ä½ç½®**: Abstract ç¬¬ä¸€å¥

**ä¿®æ”¹å‰**:
```markdown
Circular biasâ€”self-reinforcing feedback loops where AI systems reshape their training dataâ€”threatens...
```

**ä¿®æ”¹å**:
```markdown
Circular biasâ€”self-reinforcing feedback loops where artificial intelligence (AI) systems reshape their training dataâ€”threatens...
```

---

### 7. ç²¾ç®€å…³é”®è¯ï¼ˆ2åˆ†é’Ÿï¼‰

**ä½ç½®**: Abstract æœ«å°¾

**ä¿®æ”¹å‰**:
```markdown
**Keywords**: circular bias; feedback loops; AI fairness; cultural transmission; generative AI; epistemic integrity; bias mitigation; knowledge ecosystems
```

**ä¿®æ”¹å**ï¼ˆNature è¦æ±‚ 3-5 ä¸ªï¼‰:
```markdown
**Keywords**: circular bias; AI fairness; generative AI; bias mitigation; epistemic integrity
```

---

### 8. å¼€å§‹å­—æ•°ç¼©å‡ï¼ˆ1-2å°æ—¶ï¼‰

**ç›®æ ‡**: ä» ~8,000 è¯å‡å°‘åˆ° ~6,000 è¯ï¼ˆä»Šæ—¥ç›®æ ‡ï¼‰

#### ä¼˜å…ˆç¼©å‡çš„éƒ¨åˆ†ï¼š

**A. Section 3.2.5 (å½“å‰ ~1,200 è¯ â†’ ç›®æ ‡ 600 è¯)**

ç­–ç•¥ï¼š
- ä¿ç•™æ ¸å¿ƒæ¦‚å¿µï¼ˆIterated Learning, Cultural Transmissionï¼‰
- åˆ é™¤è¿‡å¤šçš„ä¾‹å­å’Œé‡å¤è§£é‡Š
- ç²¾ç®€ "Anthropological Parallels" æ®µè½
- ç§»é™¤ä¸ Section 6.2 é‡å¤çš„å†…å®¹

**B. Section 5 æ¡ˆä¾‹ç ”ç©¶ (å½“å‰ ~2,000 è¯ â†’ ç›®æ ‡ 1,200 è¯)**

ç­–ç•¥ï¼š
- æ¯ä¸ªæ¡ˆä¾‹ä¿ç•™æ ¸å¿ƒæ•°æ®å’Œç»“æœ
- åˆ é™¤è¿‡ç¨‹æè¿°
- ç²¾ç®€ Table 3ï¼ˆç§»è‡³è¡¥å……ææ–™ï¼‰

**C. Section 4 æ–¹æ³•å­¦ (å½“å‰ ~2,000 è¯ â†’ ç›®æ ‡ 1,500 è¯)**

ç­–ç•¥ï¼š
- ä¿ç•™æ¡†æ¶æ¦‚è¿°
- ç²¾ç®€æŠ€æœ¯ç»†èŠ‚
- å°†è¯¦ç»†å…¬å¼ç§»è‡³è¡¥å……ææ–™

---

## ğŸ“‹ ä»Šæ—¥å®Œæˆæ£€æŸ¥æ¸…å•

### ä¸Šåˆä»»åŠ¡ï¼ˆ9:00-12:00ï¼‰
- [ ] âœ… é˜…è¯» `NMI_SUBMISSION_CHECKLIST.md`
- [ ] ä¿®å¤ Section 2.4ï¼ˆ10åˆ†é’Ÿï¼‰
- [ ] ä¿®å¤ Section 5.1 å¼•ç”¨ï¼ˆ5åˆ†é’Ÿï¼‰
- [ ] æ·»åŠ å‚è€ƒæ–‡çŒ® [12]ï¼ˆ5åˆ†é’Ÿï¼‰
- [ ] ç»Ÿä¸€æ ·æœ¬æ•°é‡ï¼ˆ10åˆ†é’Ÿï¼‰
- [ ] å®šä¹‰ NMI ç¼©å†™ï¼ˆ2åˆ†é’Ÿï¼‰
- [ ] ä¿®æ”¹æ‘˜è¦ç¼©å†™ï¼ˆ5åˆ†é’Ÿï¼‰
- [ ] ç²¾ç®€å…³é”®è¯ï¼ˆ2åˆ†é’Ÿï¼‰

**é¢„è®¡å®Œæˆæ—¶é—´**: 40åˆ†é’Ÿ

### ä¸‹åˆä»»åŠ¡ï¼ˆ14:00-17:00ï¼‰
- [ ] ç¼©å‡ Section 3.2.5: 1,200 â†’ 600 è¯ï¼ˆ1å°æ—¶ï¼‰
- [ ] ç¼©å‡ Section 5: 2,000 â†’ 1,200 è¯ï¼ˆ1å°æ—¶ï¼‰
- [ ] ç¼©å‡ Section 4: 2,000 â†’ 1,500 è¯ï¼ˆ45åˆ†é’Ÿï¼‰
- [ ] å…¨æ–‡æ£€æŸ¥ï¼Œç¡®ä¿é€»è¾‘è¿è´¯ï¼ˆ15åˆ†é’Ÿï¼‰

**é¢„è®¡å®Œæˆæ—¶é—´**: 3å°æ—¶

---

## ğŸ¯ æˆåŠŸæ ‡å‡†

ä»Šæ—¥ç»“æŸæ—¶ï¼Œè®ºæ–‡åº”è¯¥ï¼š
1. âœ… æ²¡æœ‰ CRITICAL é”™è¯¯
2. âœ… å­—æ•°å‡å°‘åˆ° ~6,000 è¯
3. âœ… æ‰€æœ‰å¼•ç”¨æ­£ç¡®
4. âœ… æ‘˜è¦å’Œå…³é”®è¯ç¬¦åˆ Nature è¦æ±‚
5. âœ… ç»“æ„å®Œæ•´ï¼Œé€»è¾‘æ¸…æ™°

---

## ğŸ’¡ ç¼©å‡æ–‡å­—çš„æŠ€å·§

### 1. åˆ é™¤å†—ä½™è¡¨è¾¾
- "It is important to note that" â†’ åˆ é™¤
- "As mentioned previously" â†’ åˆ é™¤
- "In this section, we will discuss" â†’ ç›´æ¥è®¨è®º

### 2. åˆå¹¶ç›¸ä¼¼æ®µè½
- Section 3.2.5 å’Œ 6.2 æœ‰é‡å¤ â†’ ä¿ç•™ä¸€å¤„ï¼Œå¦ä¸€å¤„ç®€è¦å¼•ç”¨

### 3. ç²¾ç®€ä¾‹å­
- æ¯ä¸ªæ¦‚å¿µä¿ç•™ 1 ä¸ªæœ€å¼ºä¾‹å­
- åˆ é™¤æ¬¡è¦æ¡ˆä¾‹

### 4. ä½¿ç”¨è¡¨æ ¼ä»£æ›¿æ–‡å­—
- å°†æ–‡å­—æè¿°è½¬æ¢ä¸ºè¡¨æ ¼
- ä¾‹å¦‚ï¼šæ–¹æ³•æ¯”è¾ƒã€æ¡ˆä¾‹æ€»ç»“

### 5. ç§»è‡³è¡¥å……ææ–™
- è¯¦ç»†æ–¹æ³•å­¦ â†’ Supplementary Methods
- é¢å¤–æ¡ˆä¾‹ â†’ Supplementary Case Studies
- å®Œæ•´æ•°æ®è¡¨ â†’ Supplementary Tables

---

## ğŸ“ éœ€è¦å¸®åŠ©ï¼Ÿ

å¦‚æœæ‚¨éœ€è¦æˆ‘å¸®åŠ©ï¼š
1. **å…·ä½“ç¼©å‡æŸä¸ªæ®µè½** - å‘Šè¯‰æˆ‘æ®µè½ä½ç½®
2. **æ£€æŸ¥ä¿®æ”¹åçš„æ–‡å­—** - å‘é€ç»™æˆ‘å®¡é˜…
3. **è½¬æ¢å¼•ç”¨æ ¼å¼** - æˆ‘å¯ä»¥å¸®æ‚¨è½¬æ¢å‚è€ƒæ–‡çŒ®

**å¼€å§‹å·¥ä½œå§ï¼åŠ æ²¹ï¼** ğŸ’ª
